
The Blood Cancer Success Story: Part 2
The Leukemia & Lymphoma Society (LLS) has been funding research since 1949 and has helped support several FDA-approved therapies, including Yescarta, Vyxeos, Elzonris, and Copiktra. In January 2025, Lore Gruenbaum became LLS’s Chief Scientific Officer …